Larotrectinib Sulfate and Nuwiq (Antihemophilic Factor (Recombinant) (Nuwiq))
Determining the interaction of Larotrectinib Sulfate and Nuwiq (Antihemophilic Factor (Recombinant) (Nuwiq)) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: larotrectinib
Brand name: Vitrakvi
Synonyms: Larotrectinib
Generic Name: antihemophilic factor
Brand name: Hemofil-M, Koate-DVI, Monoclate-P, Advate, Adynovate, Afstyla, Eloctate with Fc Fusion Protein, Helixate FS, Kogenate FS, Kovaltry, Novoeight, Nuwiq, Recombinate, Xyntha, Jivi, Obizur
Synonyms: Antihemophilic factor (human), Antihemophilic Factor (Human)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Larotrectinib Sulfate-Nuwiq recombinant
- Larotrectinib Sulfate-NuZole
- Larotrectinib Sulfate-Nuzyra
- Larotrectinib Sulfate-Nuzyra (Omadacycline Injection)
- Larotrectinib Sulfate-Nuzyra (Omadacycline Tablets)
- Larotrectinib Sulfate-Nuzyra Intravenous
- Nuwiq (Antihemophilic Factor (Recombinant) (Nuwiq))-Lartruvo
- Nuwiq (Antihemophilic Factor (Recombinant) (Nuwiq))-Larynex
- Nuwiq (Antihemophilic Factor (Recombinant) (Nuwiq))-Laryng-O-Jet
- Nuwiq (Antihemophilic Factor (Recombinant) (Nuwiq))-Laryngesic
- Nuwiq (Antihemophilic Factor (Recombinant) (Nuwiq))-Lasix
- Nuwiq (Antihemophilic Factor (Recombinant) (Nuwiq))-Lasix Injection